The Impact of nCoV-2019 on Children With Migraine
NCT06077006 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2023-10-11
Summary
Executive functions, anxiety and their relation to social participation and quality of life among children with Migraine during COVID-19
Backgrounds: Among children, especially adolescents, migraine stands out as one of the most prevalent headache disorders. It is susceptible to stress and has the potential to affect children's emotional and cognitive status and therefore, affect their function, and notably amid the COVID-19 pandemic.
Study Objective: To compare executive functions (EF), anxiety, social participation and quality of life (QoL) between children with migraine and healthy controls, and to examine the differences of these factors between children who were infected by COVID-19 and those who were not.
Study Population:
The research will include 75 children between the ages of 6 and 18 years, diagnosed with Migraine, who are under follow-up at the Pediatric Neurology Clinic in Bnei Zion. A control group of 75 children without chronic diseases, assessed during routine visits at the Pediatric Neurology Clinic or for other reasons, will also be included.
Research Methods:
Participants will complete questionnaires related to demographic details, quality of life, sleep, and emotional status.
Inclusion Criteria:
Children between the ages of 6 and 18 years with Migraine.
Exclusion Criteria:
Children unable or unwilling to complete the questionnaires, and those with secondary headaches or other chronic illness.
Informed Consent:
Participants aged 11 and older will provide informed consent, while younger children will receive oral explanations, and their paren
Conditions
- Migraine Disorders
- COVID-19 Pandemic
Interventions
- OTHER
-
questionnaires Only
questionnaires Only
Sponsors & Collaborators
-
Bnai Zion Medical Center
lead OTHER_GOV
Principal Investigators
-
jacob Genizi, MD · Bnai Zion Medical Center
Eligibility
- Min Age
- 6 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-01
- Primary Completion
- 2023-04-30
- Completion
- 2023-07-30
Countries
- Israel
Study Locations
More Related Trials
-
Pediatric Headche Assessment Using HIT 6
NCT06598813 ·Status: COMPLETED
-
Trans-diagnostic Cognitive-behavioral Therapy for Treatment of Migraine
NCT03701477 ·Status: COMPLETED ·Phase: NA
-
Mindfulness-Based Intervention for Adolescents With Chronic Migraine
NCT06414109 ·Status: COMPLETED ·Phase: NA
-
Migraine Abortive Treatment
NCT05048914 ·Status: UNKNOWN
-
The Efficacy of Beneficial Intestinal Microbiota in the Treatment of Migraine and Its Mechanism: Basic and Clinical Studies
NCT07092241 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Non-pharmacological Treatments in Migraine.
NCT05596058 ·Status: TERMINATED ·Phase: NA
-
Adolescents With Migraine: What's Stress Got To Do With It?
NCT02259387 ·Status: COMPLETED
-
Migraine and Recurrent Abdominal Pain in Children
NCT00060619 ·Status: UNKNOWN ·Phase: NA
-
Coping Skills Training in Individuals With Migraine
NCT05809375 ·Status: UNKNOWN ·Phase: NA
-
Propranolol for Pediatric Migraine: A Prospective Clinical Study
NCT07180043 ·Status: COMPLETED ·Phase: NA
-
Acute Phase Reactions and Thrombophilia in Pediatric Patients With Migraine
NCT01905748 ·Status: UNKNOWN ·Phase: NA
-
Mindfulness for Adolescents for CM and HFEM
NCT04968093 ·Status: COMPLETED ·Phase: NA
-
A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children
NCT00237302 ·Status: COMPLETED ·Phase: PHASE3
-
Migraine Manager (R01)
NCT04567355 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treatment of Acute Migraine Headache in Children
NCT00355394 ·Status: COMPLETED ·Phase: PHASE2
-
Tryptophan Metabolites in Pediatric Migraine
NCT05969990 ·Status: UNKNOWN
-
Aerobic Exercise and Neck Exercises in Pediatric Migraine Treatment
NCT06068751 ·Status: UNKNOWN ·Phase: NA
-
Headstrong Intervention for Pediatric Headache
NCT00269581 ·Status: COMPLETED ·Phase: PHASE3
-
Defining the Sympathetic Skin Response of Migraineurs in the Facial Area
NCT03772860 ·Status: UNKNOWN
-
1H Magnetic Resonance Spectroscopy in Migraine Patients
NCT04220606 ·Status: COMPLETED ·Phase: NA
-
Improvement the Anti-migraine Treatment Efficacy by Tailoring the Drug to Individual's Pain Modulation Profile
NCT01470339 ·Status: COMPLETED ·Phase: NA
-
Familial and Environmental Factors Behind Migraine
NCT04356079 ·Status: UNKNOWN
-
Hydration in Children and Adolescents With Primary Headaches
NCT06816849 ·Status: COMPLETED ·Phase: NA
-
Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine
NCT00777218 ·Status: WITHDRAWN ·Phase: NA
-
Effectiveness of Education and Relaxation Program on Migraine Related Disability in Patients Attending Headache Clinic
NCT05039996 ·Status: UNKNOWN ·Phase: NA